Macroeconomic Headwinds Weigh on Exxon
The narrow-moat firm's earnings and cash flow have been affected, but our fair value estimate is unchanged.
Exxon (XOM) reported fourth-quarter earnings that continue to reflect the macroeconomic headwinds the company is facing across all parts of its business, which are weighing on earnings and cash flow. Our narrow moat and fair value estimate are unchanged. Fourth-quarter adjusted earnings fell to $1.8 billion from $5.2 billion last year, and full-year 2019 adjusted earnings dropped to $9.6 billion from $19.1 billion last year.
Upstream adjusted earnings in the fourth quarter slid to $2.2 billion from $3.7 billion last year as lower natural gas prices, along with higher growth-related expenses and the absence of one-time items, more than offset 5% growth in volumes and higher liquids-price realizations. Downstream adjusted earnings for the quarter fell to $898 million from $1.8 billion last year on narrower differentials, lower refining margins and higher-than-scheduled maintenance. The chemicals segment had to contend with an adjusted operating loss of $355 million this quarter compared with adjusted earnings of $525 million the year before, primarily on weaker margins as overcapacity and economic softness continue to weigh on the sector.
Cash flow from operations and asset sales, excluding working capital of $11.1 billion for the quarter compared with $10.8 billion last year, brings the full-year total to $32.5 billion in 2019, down from $41.5 billion in 2018. Integrated models usually enjoy countercyclical benefits in a variety of environments that have all been negated as a result of the difficult macroeconomic environment. Earnings have been depressed by weaker commodity prices alongside lower refining and chemical margins. The company continues to target $15 billion in asset sale proceeds through 2021 however, which should buffer operating cash flow and keep the dividend safe until commodity prices improve to midcycle levels and new projects come online. Capital and exploration expenditures were $8.5 billion, including key investments in the Permian Basin.
|Morningstar Premium Members gain exclusive access to our full analyst reports, including fair value estimates, bull and bear breakdowns, and risk analyses. Not a Premium Member? Get this and other reports immediately when you try Morningstar Premium free for 14 days.|
Allen Good does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.